Status:

COMPLETED

Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test

Lead Sponsor:

LumiraDx UK Limited

Conditions:

Anticoagulants and Bleeding Disorders

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is to evaluate the INR levels in patients taking phenprocoumon using the LumiraDx Point of Care INR test and comparing the results to the laboratory reference method , the ACL Elite Pro. Co...

Detailed Description

Vitamin K antagonists (VKA) are a group of substances that reduce blood clotting by reducing the action of vitamin K. They are used in anticoagulant medications in the prevention of thrombosis. The dr...

Eligibility Criteria

Inclusion

  • Persons \>18 years of age
  • Willing and able to provide written informed consent and comply with study procedures
  • Currently prescribed Phenprocoumon VKA Therapy
  • Deemed medically appropriate for study participation by the Investigator

Exclusion

  • Subject has previously participated in this part of the study
  • Subject is within 4 weeks of first prescription of Phenprocoumon
  • Subject is taking a DOAC, or non-Phenprocoumon VKA therapy
  • Confirmed or suspected pregnancy
  • Vulnerable populations deemed inappropriate for study by the Investigator
  • Deemed medically inappropriate for study by the Investigator (i.e. patients with a known inherited \[e.g. haemophilia or von Willebrand's disease\] or acquired \[e.g. liver cirrhosis\] condition likely to be associated with a coagulopathy; or patients receiving non-VKA anticoagulant medications)

Key Trial Info

Start Date :

May 9 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 15 2019

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT04074980

Start Date

May 9 2019

End Date

September 15 2019

Last Update

February 20 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CLINICAL SITE Klinik am See, Rehabilitation Clinic for Cardiovascular Diseases, Ruedersdorf/Berlin.

Rüdersdorf, Germany